A double blind randomized placebo controlled trial to evaluate the ability to recruit and retain HIV-1 uninfected key populations from Nairobi by enrolment into a licensed HBV vaccine study-

Principle Instigator
Prof Omu Anzala

Primary Objective:  To determine the feasibility of conducting vaccine trials among MSM-SW and FSW populations in Nairobi, evaluated using enrolment rates, retention rates and adherence to study procedures.

To collect HIV risk data associated with incident HIV infections, and track changes in risk taking behaviours over the course of the study